Logo image of SWAN.CA

BLACK SWAN GRAPHENE INC (SWAN.CA) Stock Fundamental Analysis

Canada - TSX-V:SWAN - CA09226M2094 - Common Stock

1.09 CAD
+0.06 (+5.83%)
Last: 11/19/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, SWAN scores 3 out of 10 in our fundamental rating. SWAN was compared to 14 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for SWAN as it has an excellent financial health rating, but there are worries on the profitability. SWAN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SWAN had negative earnings in the past year.
In the past year SWAN has reported a negative cash flow from operations.
SWAN had negative earnings in each of the past 5 years.
SWAN had a negative operating cash flow in each of the past 5 years.
SWAN.CA Yearly Net Income VS EBIT VS OCF VS FCFSWAN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of SWAN (-37.06%) is better than 64.29% of its industry peers.
SWAN's Return On Equity of -37.52% is fine compared to the rest of the industry. SWAN outperforms 64.29% of its industry peers.
Industry RankSector Rank
ROA -37.06%
ROE -37.52%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SWAN.CA Yearly ROA, ROE, ROICSWAN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SWAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SWAN.CA Yearly Profit, Operating, Gross MarginsSWAN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

SWAN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SWAN.CA Yearly Shares OutstandingSWAN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
SWAN.CA Yearly Total Debt VS Total AssetsSWAN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 199.50 indicates that SWAN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 199.50, SWAN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
SWAN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 199.5
ROIC/WACCN/A
WACCN/A
SWAN.CA Yearly LT Debt VS Equity VS FCFSWAN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 42.79 indicates that SWAN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 42.79, SWAN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
SWAN has a Quick Ratio of 42.79. This indicates that SWAN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SWAN (42.79) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 42.79
Quick Ratio 42.79
SWAN.CA Yearly Current Assets VS Current LiabilitesSWAN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

2

3. Growth

3.1 Past

SWAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.89%.
EPS 1Y (TTM)-111.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 187.45% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.83%
Revenue Next 2Y72.97%
Revenue Next 3Y177.5%
Revenue Next 5Y187.45%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
SWAN.CA Yearly Revenue VS EstimatesSWAN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
SWAN.CA Yearly EPS VS EstimatesSWAN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2025 2026 2027 2028 2029 0 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SWAN. In the last year negative earnings were reported.
Also next year SWAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SWAN.CA Price Earnings VS Forward Price EarningsSWAN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SWAN.CA Per share dataSWAN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SWAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLACK SWAN GRAPHENE INC

TSX-V:SWAN (11/19/2025, 7:00:00 PM)

1.09

+0.06 (+5.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-25 2025-08-25
Earnings (Next)11-26 2025-11-26
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners10.69%
Ins Owner ChangeN/A
Market Cap57.81M
Revenue(TTM)N/A
Net Income(TTM)-5.18M
Analysts84
Price Target2.55 (133.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1500%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.19
P/tB 7.25
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.26
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -37.06%
ROE -37.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 42.79
Quick Ratio 42.79
Altman-Z 199.5
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year5.83%
Revenue Next 2Y72.97%
Revenue Next 3Y177.5%
Revenue Next 5Y187.45%
EBIT growth 1Y-32.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.62%
EBIT Next 3Y34.68%
EBIT Next 5Y76.85%
FCF growth 1Y-82.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.65%
OCF growth 3YN/A
OCF growth 5YN/A

BLACK SWAN GRAPHENE INC / SWAN.CA FAQ

What is the ChartMill fundamental rating of BLACK SWAN GRAPHENE INC (SWAN.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SWAN.CA.


Can you provide the valuation status for BLACK SWAN GRAPHENE INC?

ChartMill assigns a valuation rating of 0 / 10 to BLACK SWAN GRAPHENE INC (SWAN.CA). This can be considered as Overvalued.


What is the profitability of SWAN stock?

BLACK SWAN GRAPHENE INC (SWAN.CA) has a profitability rating of 1 / 10.


How financially healthy is BLACK SWAN GRAPHENE INC?

The financial health rating of BLACK SWAN GRAPHENE INC (SWAN.CA) is 8 / 10.